Agios Pharmaceuticals (AGIO) Tax Provisions (2012 - 2025)
Agios Pharmaceuticals (AGIO) reported Tax Provisions of -$1.0 million for Q4 2025, up 88.55% on a YoY basis from -$538839.4 in Q4 2024, and up 88.55% quarter-over-quarter from -$8.9 million in Q4 2024.
Agios Pharmaceuticals (AGIO) Tax Provisions (2012 - 2025) Analysis & Trends
Agios Pharmaceuticals has reported Tax Provisions for 5 years, with the latest figure at -$1.0 million in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 88.55% year-over-year to -$1.0 million; the trailing twelve-month figure through Dec 2025 stood at $43.2 million (down 2.3% YoY), and the FY2025 full-year result was -$1.0 million, down 102.3% from the prior year.
- Tax Provisions for Q4 2025 stood at -$1.0 million, up from -$8.9 million in the prior quarter.
- The five-year high for Tax Provisions was $53.1 million in Q3 2024, with the low at -$8.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.01 Bn | 2.01 Bn | 19.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2024 | -8.88 Mn |
| Sep 30, 2024 | 53.12 Mn |
| Dec 31, 2014 | 22,000.00 |
| Sep 30, 2014 | -448,000.00 |
| Dec 31, 2013 | -3.67 Mn |
| Sep 30, 2013 | 121,000.00 |
| Jun 30, 2013 | 99,000.00 |
| Mar 31, 2013 | 190,000.00 |
| Dec 31, 2012 | 3.61 Mn |
| Sep 30, 2012 | -1.92 Mn |
| Jun 30, 2012 | -588,000.00 |